Retrospective Cohort Study
Copyright ©The Author(s) 2022.
World J Clin Cases. Feb 26, 2022; 10(6): 1775-1786
Published online Feb 26, 2022. doi: 10.12998/wjcc.v10.i6.1775
Table 3 Cox proportional hazard regression model: incidence of major adverse cardiac events
VariableUnivariate model
Multivariate model
HR (95%CI)
P value
HR (95%CI)
P value
Age > 65 yr1.199 (1.080, 1.332)0.0011.123 (1.001, 1.260)0.048
Male1.213 (0.921, 1.598)0.170
BMI1.005 (0.969, 1.042)0.782
Current smoking0.982 (0.733, 1.316)0.905
Diabetes1.135 (1.098, 1.173)< 0.0011.119 (1.079, 1.161)< 0.001
Hypertension1.122 (0.848, 1.484)0.420
eGFR < 60 (mL/min/1.73 m2)1.291 (0.936, 1.780)0.120
LVEF 0.996 (0.984, 1.008)0.540
Unstable angina1.284 (1.003, 1.644)0.0481.381 (1.071, 1.781)0.013
LDL-C > 1.8 mmol/L1.160 (1.650, 1.264)0.0011.094 (0.996, 1.201)0.060
Perioperative medications
ACEI/ARB1.077 (0.825, 1.405)0.586
Beta-blocker1.044 (0.810, 1.345)0.739
Calcium-channel blocker1.197 (0.872, 1.644)0.266
AHA/ACC classification B2/C0.848 (0.638, 1.128)0.258
Calcification1.197 (0.872, 1.644)0.266
Number of stents implanted1.186 (1.031, 1.365)0.0171.171 (1.012, 1.354)0.034
Total bilirubin
Tertile I1 (ref)1 (ref)
Tertile II0.801 (0.604, 1.063)0.1250.837 (0.627, 1.119)0.229
Tertile III0.640 (0.469, 0.875)0.0050.667 (0.485, 0.918)0.013